Actively Recruiting
Using AI and Radiomics to Predict Outcomes for Adults With Kidney Cancer After Surgery
Led by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Updated on 2025-08-12
400
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are conducting a prospective observational cohort study called AI-Kidney-Prognosis to use radiomics-based artificial intelligence models to predict clinical outcomes in patients with renal cell carcinoma following surgical treatment. The goal is to help guide clinical decisions and personalize follow-up care for these patients. The study involves analyzing imaging and clinical data from patients treated for renal cell carcinoma at Wuhan Union Hospital between August 2025 and August 2026. Participants must have had at least one abdominal CT scan before treatment and a confirmed diagnosis through tissue biopsy. No active treatments or interventions are administered as part of this observational study. Participants will be followed to monitor progression-free survival over one year after surgery. Researchers will collect and analyze imaging and clinical information to evaluate how well AI models can predict patient outcomes. The study includes regular data review and follow-up to support personalized patient care planning, with the total observation period extending for at least one year.
CONDITIONS
Brief Title
Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment
Research Team
L
Lian Yang
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
